Search Results 271-280 of 17176 for Reactivation tuberculosis

  1. Chronic Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    For cohort 1: The primary goal is to the determine the overall response rate after 6 cycles of treatment with daratumumab in combination with ibrutinib in ...

  2. Infectious Diseases Clinical Trials - Mayo Clinic Research

    ... tuberculosis. Communities During COVID – Focus Groups Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. The study seeks to understand the impacts the ...

  3. Tuberous sclerosis - Diagnosis and treatment - Mayo Clinic

    Seizure evaluation · Brain, lungs, kidneys and liver evaluation · Heart evaluation · Eye exam · Dental exam · Developmental or mental health evaluation · Genetic ...

  4. Pulmonary Medicine - Clinical trials

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; ...

  5. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    Past history of tuberculosis (TB) or active infection with TB, human immunodeficiency virus (HIV), hepatitis B or hepatitis C; Is lactating and breast ...

  6. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject has active TB or meets TB exclusionary parameters. History of any malignancy except for successfully treated nonmelanoma skin cancer (NMSC) or ...

  7. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Documentation of a negative test result for latent tuberculosis within the last 12 months, or according to routine clinical practice. Able to participate ...

  8. https://www.mayoclinic.org/spanish_organization_concepts.xml

  9. Publications - Richard D. Newcomb, M.D., M.P.H. - Mayo Clinic

    Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel. Clin Infect Dis. 2020 Jul 11; 71 (2):284-290. View PubMed ...

  10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, active tuberculosis (TB), symptomatic congestive heart failure ...